Variant report

Variant	nsv983459
Chromosome Location	chr12:34173918-34178625
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:759)
CpG islands
(count:488)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:759 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:34174965-34175535	K562	blood:	n/a	chr12:34175026-34175042 chr12:34175027-34175043
2	ARID3A	chr12:34174917-34175527	HepG2	liver:	n/a	chr12:34175026-34175042 chr12:34175027-34175043
3	ATF1	chr12:34175112-34175525	K562	blood:	n/a	n/a
4	ATF2	chr12:34175155-34175514	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr12:34175128-34175510	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF2	chr12:34174909-34175573	GM12878	blood:	n/a	n/a
7	ATF2	chr12:34175036-34175597	GM12878	blood:	n/a	n/a
8	ATF3	chr12:34175027-34175625	A549	lung:	n/a	n/a
9	ATF3	chr12:34175051-34175608	A549	lung:	n/a	n/a
10	BATF	chr12:34175171-34175544	GM12878	blood:	n/a	n/a
11	BCL11A	chr12:34175171-34175530	GM12878	blood:	n/a	n/a
12	BCL3	chr12:34175028-34175635	A549	lung:	n/a	n/a
13	BCL3	chr12:34174944-34175580	A549	lung:	n/a	n/a
14	BCLAF1	chr12:34174911-34175619	GM12878	blood:	n/a	n/a
15	BCLAF1	chr12:34174957-34175674	GM12878	blood:	n/a	n/a
16	BCLAF1	chr12:34175019-34175599	K562	blood:	n/a	n/a
17	BCLAF1	chr12:34175028-34175613	K562	blood:	n/a	n/a
18	BHLHE40	chr12:34173962-34174140	K562	blood:	n/a	n/a
19	BHLHE40	chr12:34175238-34175547	K562	blood:	n/a	n/a
20	BHLHE40	chr12:34175068-34175500	GM12878	blood:	n/a	n/a
21	BRCA1	chr12:34175047-34175619	Hela-S3	cervix:	n/a	n/a
22	BRCA1	chr12:34175247-34175453	GM12878	blood:	n/a	n/a
23	CBX3	chr12:34174956-34175530	K562	blood:	n/a	n/a
24	CBX3	chr12:34174931-34175570	K562	blood:	n/a	n/a
25	CCNT2	chr12:34175341-34175565	K562	blood:	n/a	n/a
26	CEBPB	chr12:34175151-34175418	ECC-1	luminal epithelium:	n/a	n/a
27	CEBPB	chr12:34175182-34175403	MCF-7	breast:	n/a	n/a
28	CEBPB	chr12:34175064-34175551	A549	lung:	n/a	n/a
29	CEBPB	chr12:34175132-34175376	HepG2	liver:	n/a	n/a
30	CEBPB	chr12:34175025-34175502	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chr12:34175050-34175494	K562	blood:	n/a	n/a
32	CEBPB	chr12:34175140-34175561	ECC-1	luminal epithelium:	n/a	n/a
33	CEBPB	chr12:34175080-34175477	A549	lung:	n/a	n/a
34	CEBPB	chr12:34175041-34175483	A549	lung:	n/a	n/a
35	CEBPB	chr12:34175063-34175487	IMR90	lung:	n/a	n/a
36	CEBPB	chr12:34175087-34175476	HepG2	liver:	n/a	n/a
37	CEBPB	chr12:34174895-34175630	GM12878	blood:	n/a	n/a
38	CEBPB	chr12:34175057-34175460	HepG2	liver:	n/a	n/a
39	CEBPB	chr12:34175068-34175465	MCF-7	breast:	n/a	n/a
40	CEBPB	chr12:34175063-34175463	K562	blood:	n/a	n/a
41	CEBPB	chr12:34174958-34175563	Hela-S3	cervix:	n/a	n/a
42	CEBPD	chr12:34175175-34175416	HepG2	liver:	n/a	n/a
43	CEBPD	chr12:34175280-34175506	HepG2	liver:	n/a	n/a
44	CEBPD	chr12:34175260-34175708	K562	blood:	n/a	n/a
45	CHD1	chr12:34175222-34175546	GM12878	blood:	n/a	n/a
46	CHD1	chr12:34175791-34175955	GM12878	blood:	n/a	n/a
47	CHD2	chr12:34175098-34175627	Hela-S3	cervix:	n/a	n/a
48	CHD2	chr12:34175256-34175533	HepG2	liver:	n/a	n/a
49	CHD2	chr12:34175327-34175559	K562	blood:	n/a	n/a
50	CHD2	chr12:34174979-34175621	H1-hESC	embryonic stem cell:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:34177660-34177710	GM06990	blood:	n/a
2	chr12:34175567-34175617	T-47D	breast:	n/a
3	chr12:34175454-34175504	MCF10A-Er-Src	breast:	n/a
4	chr12:34175445-34175495	NH-A	brain:	n/a
5	chr12:34175262-34175312	HCF	heart:	n/a
6	chr12:34177660-34177710	MCF10A-Er-Src	breast:	n/a
7	chr12:34175445-34175495	HIPEpiC	eye:	n/a
8	chr12:34175126-34175176	HAEpiC	amniotic membrane:	n/a
9	chr12:34175567-34175617	HAEpiC	amniotic membrane:	n/a
10	chr12:34175445-34175495	NHDF-neo	bronchial:	n/a
11	chr12:34175454-34175504	BE2_C	brain:	n/a
12	chr12:34175443-34175493	T-47D	breast:	n/a
13	chr12:34174976-34175026	HL-60	blood:	n/a
14	chr12:34175262-34175312	NH-A	brain:	n/a
15	chr12:34175454-34175504	AG04450	lung:	fetal
16	chr12:34175454-34175504	NB4	blood:	n/a
17	chr12:34175262-34175312	GM12891	blood:	n/a
18	chr12:34175443-34175493	AG09309	skin:	n/a
19	chr12:34175126-34175176	SKMC	muscle:	n/a
20	chr12:34175262-34175312	HEK293	kidney:	embryo
21	chr12:34174976-34175026	HMEC	breast:	n/a
22	chr12:34175445-34175495	SK-N-SH	brain:	n/a
23	chr12:34175567-34175617	HEK293	kidney:	embryo
24	chr12:34175454-34175504	AG09319	gingival:	n/a
25	chr12:34175443-34175493	BE2_C	brain:	n/a
26	chr12:34175445-34175495	HRE	kidney:	n/a
27	chr12:34175443-34175493	NHBE	bronchial:	n/a
28	chr12:34177660-34177710	ovcar-3	ovarian:	n/a
29	chr12:34174976-34175026	Jurkat	blood:	n/a
30	chr12:34175443-34175493	ovcar-3	ovarian:	n/a
31	chr12:34175445-34175495	AoSMC	blood vessel:	n/a
32	chr12:34175126-34175176	Jurkat	blood:	n/a
33	chr12:34175443-34175493	SK-N-SH	brain:	n/a
34	chr12:34175126-34175176	HRPEpiC	eye:	n/a
35	chr12:34174976-34175026	AG09309	skin:	n/a
36	chr12:34177660-34177710	HCM	heart:	n/a
37	chr12:34175126-34175176	CMK	blood:	n/a
38	chr12:34175445-34175495	K562	blood:	n/a
39	chr12:34175567-34175617	AoSMC	blood vessel:	n/a
40	chr12:34175443-34175493	HEK293	kidney:	embryo
41	chr12:34175445-34175495	H1-hESC	embryonic stem cell:	embryo
42	chr12:34174976-34175026	ovcar-3	ovarian:	n/a
43	chr12:34175567-34175617	HPAEpiC	pulmonary alveolar:	n/a
44	chr12:34175454-34175504	SAEC	small airway:	n/a
45	chr12:34177660-34177710	AG04449	skin:	fetal
46	chr12:34174976-34175026	SKMC	muscle:	n/a
47	chr12:34174976-34175026	GM12891	blood:	n/a
48	chr12:34175445-34175495	HCF	heart:	n/a
49	chr12:34177660-34177710	H1-hESC	embryonic stem cell:	embryo
50	chr12:34174976-34175026	AoSMC	blood vessel:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:33590585..33592422-chr12:34176176..34177683,2	MCF-7	breast:
2	chr12:34175001..34175865-chr12:38710413..38711151,3	HCT-116	colon:
3	chr12:32908405..32909605-chr12:34174701..34175708,3	MCF-7	breast:

No data

Variant related genes	Relation type
ALG10	TF binding region
ALG10	CpG island
ENSG00000175548	chromatin interactions
ENSG00000139131	chromatin interactions

Extended variants
information (count: 207 )
Associated
traits (count: 50 )

Variant overlapped rSNPs/rCNVs (count:207 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs181372505	chr12:34173923-34173924	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs1687035	chr12:34173962-34173963	Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs534895855	chr12:34174017-34174018	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs7298680	chr12:34174091-34174092	Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs574543016	chr12:34174153-34174154	Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs536748024	chr12:34174224-34174225	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs556975439	chr12:34174232-34174233	Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs576853182	chr12:34174233-34174234	Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs545438163	chr12:34174278-34174279	Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs186026494	chr12:34174318-34174319	Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs573234916	chr12:34174399-34174400	Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs1687033	chr12:34174407-34174408	Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs374695401	chr12:34174474-34174475	Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs112673044	chr12:34174487-34174488	Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs190788993	chr12:34174507-34174508	Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs531086929	chr12:34174548-34174549	Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs368233268	chr12:34174559-34174560	Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs184027612	chr12:34174574-34174575	Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs533464329	chr12:34174578-34174579	Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs370935442	chr12:34174689-34174690	Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs540423915	chr12:34174705-34174706	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs547046852	chr12:34174706-34174707	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs1705772	chr12:34174756-34174757	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs34990462	chr12:34174762-34174763	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs528413768	chr12:34174775-34174776	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs544610150	chr12:34174812-34174813	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs548416147	chr12:34174815-34174816	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs188774713	chr12:34174830-34174831	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs573999944	chr12:34174877-34174878	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs190872512	chr12:34174898-34174899	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs563621663	chr12:34174912-34174913	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs530829737	chr12:34174944-34174945	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs1705771	chr12:34174950-34174951	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs539130077	chr12:34174961-34174962	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs552564652	chr12:34174962-34174963	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs562443311	chr12:34174982-34174983	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs572477036	chr12:34175051-34175052	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs542120834	chr12:34175052-34175053	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs1687032	chr12:34175126-34175127	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs1687031	chr12:34175135-34175136	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs575838946	chr12:34175153-34175154	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs182630885	chr12:34175162-34175163	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs372362814	chr12:34175166-34175167	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs564502534	chr12:34175168-34175169	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs12582932	chr12:34175174-34175175	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs200979364	chr12:34175185-34175186	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs535695327	chr12:34175205-34175206	Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs71460968	chr12:34175215-34175216	Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs533501825	chr12:34175233-34175234	Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs371512448	chr12:34175285-34175286	Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:50)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Acute myeloid leukemia	16864856	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	21509527	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Cancer	21129771	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chordoma	18071362	CNVD
Lung cancer	18438408	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD

Chromatin state (count:481 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:34171000-34174200	Weak transcription	Monocytes-CD14+_RO01746	blood
2	chr12:34174000-34174200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
3	chr12:34174000-34174200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
4	chr12:34174000-34174200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr12:34174000-34174200	Flanking Bivalent TSS/Enh	NHDF-Ad	bronchial
6	chr12:34174000-34174400	Enhancers	Brain Angular Gyrus	brain
7	chr12:34174000-34174400	Enhancers	Brain Inferior Temporal Lobe	brain
8	chr12:34174000-34174400	Enhancers	K562	blood
9	chr12:34174000-34174600	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr12:34174000-34174600	Enhancers	Dnd41	blood
11	chr12:34174000-34174600	Enhancers	Hela-S3	cervix
12	chr12:34174000-34174600	Enhancers	HUVEC	blood vessel
13	chr12:34174000-34174800	Enhancers	Primary monocytes fromperipheralblood	blood
14	chr12:34174200-34174400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr12:34174200-34174400	Enhancers	Primary hematopoietic stem cells short term culture	blood
16	chr12:34174200-34174400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
17	chr12:34174200-34174400	Enhancers	Fetal Heart	heart
18	chr12:34174200-34174400	Flanking Active TSS	NHDF-Ad	bronchial
19	chr12:34174200-34174400	Enhancers	Osteobl	bone
20	chr12:34174200-34174600	Enhancers	Primary hematopoietic stem cells	blood
21	chr12:34174200-34174600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr12:34174200-34174600	Enhancers	Brain Anterior Caudate	brain
23	chr12:34174200-34174600	Enhancers	Brain Cingulate Gyrus	brain
24	chr12:34174200-34174600	Enhancers	Brain Substantia Nigra	brain
25	chr12:34174200-34174600	Enhancers	Colon Smooth Muscle	Colon
26	chr12:34174200-34174600	Enhancers	Pancreatic Islets	Pancreatic Islet
27	chr12:34174200-34174600	Enhancers	Rectal Smooth Muscle	rectum
28	chr12:34174200-34174600	Enhancers	Monocytes-CD14+_RO01746	blood
29	chr12:34174200-34174800	Enhancers	Primary T cells from cord blood	blood
30	chr12:34174200-34174800	Enhancers	Primary T killer memory cells from peripheral blood	blood
31	chr12:34174200-34174800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr12:34174200-34174800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr12:34174200-34175000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr12:34174200-34176000	Active TSS	Psoas Muscle	Psoas
35	chr12:34174400-34174600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr12:34174400-34174600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
37	chr12:34174400-34174600	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr12:34174400-34174600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
39	chr12:34174400-34174600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
40	chr12:34174400-34174600	Enhancers	Primary B cells from cord blood	blood
41	chr12:34174400-34174600	Active TSS	Adipose Nuclei	Adipose
42	chr12:34174400-34174600	Enhancers	Liver	Liver
43	chr12:34174400-34174600	Enhancers	Duodenum Mucosa	Duodenum
44	chr12:34174400-34174600	Enhancers	Fetal Stomach	stomach
45	chr12:34174400-34174600	Enhancers	HMEC	breast
46	chr12:34174400-34174600	Flanking Active TSS	K562	blood
47	chr12:34174400-34174600	Flanking Active TSS	Osteobl	bone
48	chr12:34174400-34174800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr12:34174400-34174800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
50	chr12:34174400-34174800	Enhancers	Primary T helper cells PMA-I stimulated	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links